Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Hepatology. 2018 Dec 18;69(1):270–281. doi: 10.1002/hep.30139

Table 1.

Baseline Characteristics of Patients with HPS Compared to those without HPS (All Comers)

HPS
(N=75)
No HPS
(N=288)

PValue
Age, Median (IQR), years 56 (52, 61) 58 (52, 63) 0.09
Sex, N (%) 0.16
 Female 32 (42.7) 98 (34.0)
 Male 43 (57.3) 190 (66.0)
Race/Ethnicity, N (%) 0.02
 Non-Hispanic White 61 (81.3) 196 (68.1)
 Black 2 (2.7) 29 (10.1)
 Hispanic 12 (16.0) 49 (17.0)
 Other 0 (0.0) 14 (4.8)
Body Mass Index (BMI), Mean (SD) 31.1 (7.0) 30.6 (7.0) 0.57
Liver Disease Etiology, N (%)*
 Alcohol 31 (41.3) 112 (38.9) 0.70
 Autoimmune Hepatitis 3 (4.0) 11 (3.8) 1.00
 Cryptogenic 3 (4.0) 16 (5.6) 0.77
 Hepatitis C 34 (45.3) 112 (39.9) 0.31
 Non-alcoholic Fatty Liver Disease 8 (10.7) 44 (15.3) 0.31
 Primary Biliary Cholangitis 8 (10.7) 14 (4.9) 0.06
 Primary Sclerosing Cholangitis 4 (5.3) 11 (3.8) 0.52
HCC, N (%) 20 (26.7) 86 (33.3) 0.27
Liver Disease Manifestations, N (%)
 Ascites 57 (76.0) 201 (69.8) 0.29
 Gastrointestinal bleeding (Variceal) 27 (36.0) 89 (30.9) 0.40
 Hepatic Encephalopathy 47 (62.7) 166 (57.6) 0.43
 Hepatic Hydrothorax 9 (12.0) 35 (12.2) 0.97
Liver Disease Severity, Median (IQR)
 MELD Score, (N=358) 14 (12, 17) 13 (10, 16) 0.08
 MELD-Na Score, (N=357) 15 (12, 19) 14 (10, 18) 0.06
 CTP Score, (N=363) 7 (6, 8) 6 (5, 7) 0.01
Laboratory Studies, Median (IQR)
 Albumin, g/dL (N=361) 3.1 (2.5, 3.4) 3.1 (2.8, 3.6) 0.06
 Bilirubin, Total, mg/dL (N=362) 2.5 (1.6, 3.7) 1.7 (1.0, 3.2) 0.002
 Creatinine, mg/dL (N=362) 1.0 (1.0, 1.1) 1.0 (1.0, 1.2) 0.05
 INR (N=359) 1.4 (1.2, 1.6) 1.3 (1.2, 1.5) 0.06
 Sodium, mEq/L (N=361) 138 (134, 141) 139 (135, 141) 0.56
Signs and Symptoms, N (%)
 Clubbing 9 (12.0) 16 (5.6) 0.05
 Dyspnea 28 (37.3) 102 (35.4) 0.76
 NYHA Functional Class
  1 12 (16.0) 100 (34.7) 0.01
  2 43 (57.3) 123 (42.7)
  3 20 (26.7) 63 (21.9)
  4 0 (0.0) 2 (0.7)
*

Etiologies of liver disease are not mutually exclusive. IQR – Interquartile Range; SD – Standard Deviation, MELD – Model for End-Stage Liver Disease; CTP - Child-Turcotte-Pugh; NYHA – New York Heart Association.